News Conference News EuroPCR 2025 ‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI Michael O'Riordan May 29, 2025
News Conference News EuroPCR 2025 Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI L.A. McKeown May 22, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News EuroPCR 2023 QFR More Consistent Than FFR in Nonculprit Lesions After STEMI Caitlin E. Cox May 24, 2023
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News EuroPCR 2021 Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate Caitlin E. Cox May 24, 2021
News Conference News EuroPCR 2021 Subcutaneous GP IIb/IIIa Inhibitor in STEMI Is Fast, Potent in Early Study Todd Neale May 18, 2021
News Conference News EuroPCR 2019 Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years Michael O'Riordan May 27, 2019
News Conference News EuroPCR 2019 Long-term Ticagrelor Monotherapy May Have an Edge in Complex PCI Patients: GLOBAL LEADERS Michael O'Riordan May 21, 2019
News Conference News EuroPCR 2018 Ticagrelor Doesn’t Carry Any Off-Target Effects Compared With Clopidogrel, Prasugrel Yael L. Maxwell May 30, 2018
News Conference News EuroPCR 2013 PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients Caitlin E. Cox May 22, 2013
News Conference News RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose Caitlin E. Cox May 18, 2011